• Citer

Avelumab Plus Talazoparib in Patients with BRCA1/2 - Or ATM -Altered Advanced Solid Tumors: Results from JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial

par Schram, Alison A.M.;Colombo, Nicoletta;Arrowsmith, Edward;Narayan, Vivek;Yonemori, Kan;Scambia, Giovanni;Zelnak, Amelia A.B.;Bauer, Todd T.M.;Jin, Ning;Ulahannan, Susanna S.V.;Colleoni, Marco Angelo;Aftimos, Philippe ;Donoghue, Mark M.T.A.;Rosen, Ezra;Rudneva, Vasilisa V.A.;Telli, Melinda M.L.;Domchek, Susan S.M.;Galsky, Matthew David;Hoyle, Margaret;Chappey, Colombe;Stewart, Ross;Blake-Haskins, John J.A.;Yap, Timonthy Anthony
Référence JAMA oncology, 9, 7, page (1009)
Publication Publié, 2023-07

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Avelumab Plus Talazoparib in Patients with BRCA1/2 - Or ATM -Altered Advanced Solid Tumors: Results from JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial
Auteur:	Schram, Alison A.M.; Colombo, Nicoletta; Arrowsmith, Edward; Narayan, Vivek; Yonemori, Kan; Scambia, Giovanni; Zelnak, Amelia A.B.; Bauer, Todd T.M.; Jin, Ning; Ulahannan, Susanna S.V.; Colleoni, Marco Angelo; Aftimos, Philippe; Donoghue, Mark M.T.A.; Rosen, Ezra; Rudneva, Vasilisa V.A.; Telli, Melinda M.L.; Domchek, Susan S.M.; Galsky, Matthew David; Hoyle, Margaret; Chappey, Colombe; Stewart, Ross; Blake-Haskins, John J.A.; Yap, Timonthy Anthony
Informations sur la publication:	JAMA oncology, 9, 7, page (1009)
Statut de publication:	Publié, 2023-07
Sujet CREF:	Généralités
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2374-2437
	info:doi/10.1001/jamaoncol.2022.5218
	info:scp/85146766761
	info:pmid/36394867